63 articles, transcripts, and reports
Johnson & Johnson (NYSE: JNJ) is probably the most diversified healthcare firm that owns several popular consumer brands, which have brought both accolades and brickbats…
Johnson & Johnson (NYSE: JNJ) Q1 2022 earnings call dated Apr. 19, 2022 Corporate Participants: Joseph J. Wolk — Executive Vice President, Chief Financial Officer Jessica Moore — Vice…
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2022 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $23.4 billion,…
Johnson & Johnson (NYSE: JNJ) Q4 2021 earnings call dated Jan. 25, 2022 Corporate Participants: Jessica Moore — Vice President, Investor Relations Joseph J. Wolk — Executive Vice President, Chief…
Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $24.8 billion,…
Johnson & Johnson (NYSE: JNJ) Q3 2021 Earnings Conference
Johnson & Johnson (NYSE: JNJ) Q3 2021 earnings call dated Oct. 19, 2021 Corporate Participants: Sarah Wood — Senior Director, Investor Relations Joseph J. Wolk — Executive Vice President,…
Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $23.3 billion,…
Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Christopher DelOrefice — Vice President, Investor Relations Joseph J. Wolk — Executive Vice President,…
Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Christopher DelOrefice — Vice President, Investor Relations Joseph J. Wolk — Executive Vice President, Chief…
